Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 170

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

On the Estimation of the Cost-Effectiveness Threshold: Why, What, How?

Open access
Vallejo-Torres, Laura, García-Lorenzo, Borja, Castilla, Iván, Valcárcel-Nazco, Cristina, García-Pérez, Lidia, Linertová, Renata, Polentinos-Castro, Elena, Serrano-Aguilar, Pedro · 2016 · Value in Health

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jval.2016.02.020

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 49

  1. Kaplan, 1982, Health-related quality of life measurement for evaluation research and policy analysis, Health Psychol, 1, 61, 10.1037/0278-6133.1.1.61 · DOI · Paper page
  2. Laupacis, 1992, How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations, CMAJ, 146, 473
  3. Bridges, 2010, Healthcare rationing by proxy: cost-effectiveness analysis and the misuse of the $50,000 threshold in the US, Pharmacoeconomics, 28, 175, 10.2165/11530650-000000000-00000 · DOI
  4. Ryen, 2015, The willingness to pay for a quality adjusted life year: a review of the empirical literature, Health Econ, 24, 1289, 10.1002/hec.3085 · DOI · Paper page
  5. Bobinac, 2010, Willingness to pay for a quality-adjusted life-year: the individual perspective, Value Health, 13, 1046, 10.1111/j.1524-4733.2010.00781.x · DOI
  6. Birch, 1993, Changing the problem to fit the solution: Johannesson and Weinstein’s (mis) application of economics to real world problems, J Health Econ, 12, 469, 10.1016/0167-6296(93)90006-Z · doi:10.1016/0167-6296(93)90006-z
  7. Birch, 2006, The biggest bang for the buck or bigger bucks for the bang: the fallacy of the cost-effectiveness threshold, J Health Serv Res Policy, 11, 46, 10.1258/135581906775094235 · DOI
  8. Gafni, 2006, Incremental cost-effectiveness ratios (ICERs): the silence of the lambda, Soc Sci Med, 62, 2091, 10.1016/j.socscimed.2005.10.023 · DOI · Paper page
  9. Mccabe, 2008, Cost-effectiveness threshold: what it is and what that means, Pharmacoeconomics, 26, 733, 10.2165/00019053-200826090-00004 · DOI · Paper page
  10. Eichler, 2004, Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?, Value Health, 7, 518, 10.1111/j.1524-4733.2004.75003.x · DOI · Paper page
  11. Phelps, 1991, On the (near) equivalence of cost-effectiveness and cost-benefit analyses, Int J Technol Assess Health Care, 7, 12, 10.1017/S0266462300004803 · DOI · Paper page
  12. Baker, 2011, Searchers vs surveyors in estimating the monetary value of a QALY: resolving a nasty dilemma for NICE, Health Econ Policy Law, 6, 435, 10.1017/S1744133111000181 · DOI
  13. Claxton, 2015, Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold, Health Technol Assess, 19, 1, 10.3310/hta19140 · DOI · Paper page
  14. Culyer, 2007, Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence, J Health Serv Res Policy, 12, 56, 10.1258/135581907779497567 · DOI · Paper page
  15. Mason, 2009, Modelling the monetary value of a QALY: a new approach based on UK data, Health Econ, 18, 933, 10.1002/hec.1416 · doi:10.1002/hec.1416
  16. Blumenschein, 1998, Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma, Ann Allergy Asthma Immunol, 80, 189, 10.1016/S1081-1206(10)62954-7 · DOI
  17. Zethraeus, 1998, Willingness to pay for hormone replacement therapy, Health Econ, 7, 31, 10.1002/(SICI)1099-1050(199802)7:1<31::AID-HEC316>3.0.CO;2-7 · doi:10.1002/(sici)1099-1050(199802)7:1<31::aid-hec316>3.0.co;2-7
  18. Cunningham, 2000, Relationship between utility values and willingness to pay in patients undergoing orthognathic treatment, Community Dent Health, 17, 92
  19. Gyrd-Hansen, 2003, Willingness to pay for a QALY, Health Econ, 12, 1049, 10.1002/hec.799 · DOI · Paper page
  20. Byrne, 2005, Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis, Med Decis Making, 25, 655, 10.1177/0272989X05282638 · DOI
  21. King, 2005, Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation, Med Decis Making, 25, 667, 10.1177/0272989X05282640 · DOI · Paper page
  22. Pinto Prades, 2005, Estimacion del valor monetario de los anos de vida ajustados por calidad: Estimaciones preliminares, Ekonomiaz, I, 192, 10.69810/ekz.0773 · doi:10.69810/ekz.0773
  23. Lieu, 2009, Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster, Pharmacoeconomics, 27, 1005, 10.2165/11314000-000000000-00000 · DOI
  24. Pinto-Prades, 2009, Trying to estimate a monetary value for the QALY, J Health Econ, 28, 553, 10.1016/j.jhealeco.2009.02.003 · DOI
  25. Shiroiwa, 2010, International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?, Health Econ, 19, 422, 10.1002/hec.1481 · DOI · Paper page
  26. Baker, 2010, Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project, Health Technol Assess., 14, 1, 10.3310/hta14270 · DOI · Paper page
  27. Donaldson, 2011, The social value of a QALY: raising the bar or barring the raise?, BMC Health Serv Res, 11, 8, 10.1186/1472-6963-11-8 · doi:10.1186/1472-6963-11-8
  28. Zhao, 2011, Willingness to pay per quality-adjusted life year: is one threshold enough for decision-making?: results from a study in patients with chronic prostatitis, Med Care, 49, 267, 10.1097/MLR.0b013e31820192cd · doi:10.1097/mlr.0b013e31820192cd
  29. Soini, 2012, Contingent Valuation of Eight New Treatments: What is the Clinician’s and Politician’s Willingness to Pay?, Open Complement Med J, 4, 1, 10.2174/1876391X01204010001 · DOI
  30. Shiroiwa, 2013, WTP for a QALY and health states: More money for severer health states?, Cost Eff Resour Alloc, 11, 22, 10.1186/1478-7547-11-22 · DOI
  31. Bobinac, 2013, Valuing qaly gains by applying a societal perspective, Health Econ, 22, 1272, 10.1002/hec.2879 · DOI
  32. Thavorncharoensap, 2013, Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?, Clinicoecon Outcomes Res, 5, 29, 10.2147/CEOR.S38062 · DOI
  33. Robinson, 2013, Estimatinga WTP-based value of a QALY: the “chained” approach, Soc Sci Med, 92, 92, 10.1016/j.socscimed.2013.05.013 · DOI
  34. Pennington, 2013, Comparing WTP values of different types of QALY gain elicited from the general public, Health Econ, 24, 280, 10.1002/hec.3018 · DOI
  35. Bobinac, 2014, The value of a QALY: individual willingness to pay for health gains under risk, Pharmacoeconomics, 32, 75, 10.1007/s40273-013-0110-1 · DOI
  36. Martín-Fernández, 2014, Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences, BMC Health Serv Res, 14, 287, 10.1186/1472-6963-14-287 · DOI
  37. Bobinac, 2012, Get more, pay more? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation, J Health Econ, 31, 158, 10.1016/j.jhealeco.2011.09.004 · DOI
  38. Gyrd-Hansen, 2012, Disentangling WTP per QALY data: different analytical approaches, different answers, Health Econ, 21, 222, 10.1002/hec.1709 · doi:10.1002/hec.1709
  39. Haninger, 2011, Diminishing willingness to pay per quality-adjusted life year: valuing acute foodborne illness, Risk Anal, 31, 1363, 10.1111/j.1539-6924.2011.01617.x · DOI
  40. Hirth, 2000, Willingness to Pay for a Quality-adjusted Life Year: In Search of a Standard, Med Decis Mak, 20, 332, 10.1177/0272989X0002000310 · DOI · Paper page
  41. Towse, 2009, Should NICE’s threshold range for cost per QALY be raised? Yes, BMJ, 338, b181, 10.1136/bmj.b181 · DOI
  42. Appleby, 2009, Searching for cost effectiveness thresholds in the NHS, Health Policy, 91, 239, 10.1016/j.healthpol.2008.12.010 · DOI
  43. George, 2001, Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in Australia (1991 to 1996), Pharmacoeconomics, 19, 1103, 10.2165/00019053-200119110-00004 · DOI · Paper page
  44. Devlin, 2004, Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis, Health Econ, 13, 437, 10.1002/hec.864 · DOI · Paper page
  45. Chambers, 2010, Does Medicare have an implicit cost-effectiveness threshold?, Med Decis Making, 30, E14, 10.1177/0272989X10371134 · DOI
  46. Nimdet, 2015, A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?, PLoS One, 10, e0122760, 10.1371/journal.pone.0122760 · DOI
  47. Lichtenberg, 2004, Sources of U.S. longevity increase, 1960–2001, Q Rev Econ Financ, 44, 369, 10.1016/j.qref.2004.05.005 · DOI
  48. Martin, 2008, Does health care spending improve health outcomes? Evidence from English programme budgeting data, J Health Econ, 27, 826, 10.1016/j.jhealeco.2007.12.002 · DOI · Paper page
  49. Martin, 2012, Comparing costs and outcomes across programmes of health care, Health Econ, 21, 316, 10.1002/hec.1716 · DOI

Cited by

See all 170

Metadata

Authors
Vallejo-Torres, L., García-Lorenzo, B., Castilla, I., Valcárcel-Nazco, C., García-Pérez, L., Linertová, R., Polentinos-Castro, E., & Serrano-Aguilar, P.
Venue
Value in Health
Publisher
Elsevier BV
Published
2016-07
Volume
19
Issue
5
Pages
558-566
ISSN
1098-3015 (ISSN-L)
OpenAlex
W2337377794
Cited by
170
References
3
FWCI
27.73
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: On the Estimation of the Cost-Effectiveness Threshold: Why, What, How? https://app.cochat.ai/papers/10.1016/j.jval.2016.02.020
The paper
Vallejo-Torres, L., García-Lorenzo, B., Castilla, I., Valcárcel-Nazco, C., García-Pérez, L., Linertová, R., Polentinos-Castro, E., & Serrano-Aguilar, P. (2016). On the Estimation of the Cost-Effectiveness Threshold: Why, What, How? Value in Health. https://doi.org/10.1016/j.jval.2016.02.020

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.